Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-03-27 @ 7:24 PM
Study NCT ID:
NCT01271712
Status:
COMPLETED
Last Update Posted:
2021-01-29
First Post:
2010-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)
Sponsor:
Bayer
Organization: